112 completed, 17 terminated, 12 recruiting, 12 unknown. 79 Phase 1, 29 Phase 2, 26 Phase 3, 23 Not applicable, 19 Phase 4.
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS) Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] - Vesico-Ureteral Reflux | Phase 1 | Not yet recruiting | Boston Children's Hospital | 70 | 2027-07-01 | 2026-07-22 |
| Aprepitant for the Treatment of CLIFAHDD Aprepitant Powder for Oral Suspension - CLIFAHDD, Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 5 | 2026-10-31 | 2026-10-05 |
| CEUS Evaluation of Hydrocephalus in Neonates and Infants Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON] - Hydrocephalus in Infants, Hydrocephalus Acquired | Phase 2 | Recruiting | Children's Hospital of Philadelphia | 20 | 2026-10-15 | 2026-09-16 |
| Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study) triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain | Phase 4 | Recruiting | Igor Wilderman. MD | 500 | 2026-07-30 | 2026-08-13 |
| A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults Sonrotoclax Tablet for Oral Suspension, Sonrotoclax Tablet - Healthy Volunteers | Phase 1 | Completed | BeOne Medicines | 12 | 2026-06-17 | 2026-10-23 |
| A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults GS3-007a for Suspension, Placebo GS3-007a for Suspension - Healthy Adults | Phase 1 | Recruiting | Changchun GeneScience Pharmaceutical Co., Ltd. | 32 | 2026-01-07 | 2026-03-16 |
| Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza ZX-7101A for oral suspension, Oseltamivir phosphate for oral suspension - Respiratory Viral Infection | Phase 3 | Completed | Nanjing Zenshine Pharmaceuticals | 169 | 2025-10-13 | 2026-04-16 |
| Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions RLF-OD032 100 mg/mL oral suspension, Kuvan 100 MG Powder for Oral Solution - Bioequivalence | Phase 1 | Completed | APR Applied Pharma Research s.a. | 42 | 2025-08-20 | 2026-04-28 |
| A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension test formulation(T) 200 mg deuteriumremidvir hydrobromide for suspension, reference formulation(R) 100 mg deuteriumremidvir hydrobromide for suspension - Healthy Participants | Phase 1 | Completed | Vigonvita Life Sciences | 18 | 2025-08-11 | 2025-11-21 |
| Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection Likmez® (metronidazole) Oral Suspension - Bacterial Infections | Phase 2 | Not yet recruiting | Saptalis Pharmaceuticals LLC | 30 | 2025-08-01 | 2025-08-28 |
| Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study) Amoxicillin-Clavulanic acid 600mg - 42.9 mg/ 5 mL oral suspension, Saccharomyces boulardii CNCM I-745 - Antibiotic Associated Diarrhea, Acute Otitis Media | Phase 4 | Completed | Eskisehir Osmangazi University | 100 | 2025-08-01 | 2026-09-11 |
| Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation AQ280 Capsule, AQ280 Tablet for Oral Suspension, Placebo Capsule - Eosinophilic Esophagitis | Phase 1 | Completed | AQILION AB | 9 | 2025-06-13 | 2026-06-01 |
| Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ) Stiripentol capsule (Diacomit®), Stiripentol oral suspension (Diacomit®) - Dravet Syndrome, Epilepsy | Phase 1 | Completed | Biocodex | 24 | 2025-06-01 | 2025-09-16 |
| Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment Triamcinolone Acetonide 1 ml of 40 mg/mL suspension, Verapamil Injection - Keloid Scars | Phase 4 | Not yet recruiting | Nishtar Medical University | 60 | 2025-04-01 | 2025-04-01 |
| A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy vamorolone 40 mg/mL oral suspension - Duchenne Muscular Dystrophy | Phase 4 | Active not recruiting | Santhera Pharmaceuticals | 80 | 2024-11-10 | 2026-04-23 |
| Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects GP681 tablet, GP681 Powder for Oral Suspension - Healthy Participants | Phase 1 | Completed | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 36 | 2024-09-27 | 2025-03-14 |
| RSV Vaccination in Immunocompromised Patients. Arexvy powder and suspension for injection - RSV Infection | Phase 2 | Recruiting | Medical University of Vienna | 200 | 2024-09-19 | 2024-11-27 |
| A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml) PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg - Relative Bioavailability | Phase 1 | Completed | TrippBio, Inc. | 14 | 2024-09-01 | 2024-11-21 |
| Lumason® Infusion vs. Bolus Administrations Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON], Lumason - Heart Diseases | Phase 3 | Recruiting | Bracco Diagnostics, Inc | 106 | 2024-07-10 | 2026-10-20 |
| Evaluating the Human Immune Response to the JYNNEOS Vaccine JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) suspension for subcutaneous injection, Phlebotomy, Research bronchoscopy - Vaccinia, Virus Diseases | Early Phase 1 | Active not recruiting | Washington University School of Medicine | 20 | 2024-06-10 | 2026-10-21 |
Showing 20 of 168. Sign in to see all of them.
Hyperkalemia (10) · Renal Insufficiency, Chronic (6) · Neoplasm Metastasis (4) · Neoplasms (4) · Bacterial Infections (3) · COVID-19 (3) · Glaucoma, Open-Angle (3) · HIV Infections (3) · Ocular Hypertension (3) · Premature Birth (3) · Respiratory Syncytial Virus Infections (3) · Alzheimer Disease (2) · Attention Deficit Disorder with Hyperactivity (2) · Cystic Fibrosis (2) · Deglutition Disorders (2)
Bayer (7) · Ranbaxy Laboratories Limited (7) · Teva Pharmaceuticals USA (6) · NanOlogy, LLC (5) · ParaPRO LLC (5) · Relypsa, Inc. (5) · Sandoz (5) · Alcon Research (4) · Pfizer (4) · University of California, San Francisco (4) · Vigonvita Life Sciences (4) · Aziende Chimiche Riunite Angelini Francesco S.p.A (3) · ImmunityBio, Inc. (3) · Lakefront Biotherapeutics NV (3) · Merck Sharp & Dohme LLC (3)
United States (61) · Canada (16) · United Kingdom (13) · China (11) · Germany (8) · Italy (8) · France (7) · Belgium (6) · India (6) · Netherlands (6) · Australia (5) · Brazil (5) · Spain (5) · Switzerland (5) · Denmark (4)
Bill Miller, MD (2) · Julian Platon, MD, PhD (2) · Kerry W Mettert, MBA (2) · Magdy L. Shenouda, M.D. (2) · Milko Radicioni, MD (2) · Paul Y. Tam,, MD (2) · Shelagh Verco, PhD (2) · Soran Hong, M.D. (2)
PMID 32588430, PMID 15039276, PMID 15232472, PMID 17384373, PMID 18538406, PMID 18587624, PMID 19365194, PMID 19668532, PMID 20554982, PMID 20564750, PMID 21212103, PMID 21420883, PMID 22541418, PMID 22649265, PMID 23468553, PMID 23559821, PMID 23700341, PMID 24145879, PMID 24381222, PMID 24500152, PMID 25035839, PMID 25723140, PMID 25770814, PMID 26156797, PMID 28287489, PMID 29266308, PMID 29767459, PMID 29893452, PMID 30176673, PMID 30527329, PMID 31012984, PMID 31533906, PMID 31901394, PMID 31972249, PMID 32551947, PMID 32682946, PMID 32873314, PMID 33340343, PMID 33464336, PMID 33710976, PMID 34136782, PMID 34379314, PMID 34505846, PMID 34694878, PMID 34814185, PMID 34817414, PMID 34945097, PMID 35369022, PMID 35405099, PMID 35489377
2015 (6), 2016 (3), 2014 (2), 2018 (2), 2019 (2), 2005 (1), 2017 (1), 2023 (1), R01AG057681 (1)